Overview

Quick Start Initiation of the Contraceptive Vaginal Ring in Adolescents

Status:
Terminated
Trial end date:
2010-07-01
Target enrollment:
0
Participant gender:
Female
Summary
We hypothesize that using "quick start" initiation of the contraceptive vaginal ring in adolescents seeking birth control will improve compliance compared to traditional start. We will conduct a randomized controlled trial comparing "quick start" to traditional start initiation of the contraceptive vaginal ring in adolescents seeking birth control. The primary study outcome is method continuation at 3, 6, and 12 months. Secondary outcomes include abnormal bleeding, product satisfaction, and adverse events.
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Virginia Commonwealth University
Collaborators:
American College of Obstetricians and Gynecologists
Bayer
Treatments:
Contraceptive Agents
NuvaRing
Criteria
Inclusion Criteria: 1) female aged 15 through 21 presenting for contraception; 2) willing
to use the NuvaRing as their contraceptive method; 3) English-speaking; 4) up to date on
routine health maintenance screening (pap smear within 3 years of initiation of sexual
intercourse and Gonorrhea/ Chlamydia testing yearly or with each new partner); and 5) able
to read and understand the consent form.

Exclusion Criteria: 1) are pregnant; 2) have a contraindication to hormonal contraception;
3) are unwilling to use NuvaRing as their contraceptive method; 4) are currently using any
hormonal contraceptive or have used one within past 2 months; 5) have used emergency
contraception in the past 7 days; 6) have had unprotected intercourse in the past 10 days;
7) have untreated Gonorrhea or Chlamydia; or 8) are unable to give informed consent because
of psychiatric or cognitive problems.